Federation des caisses Desjardins du Quebec’s Relay Therapeutics RLAY Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$101K	Buy	+5,419	New	+$78.7K	﹤0.01%	1760

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's RLAY Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 5,419 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #1760 among its holdings.

258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

Federation des caisses Desjardins du Quebec held 5,419 shares of Relay Therapeutics worth $101K as of Q2 2026.
Relay Therapeutics was a new Federation des caisses Desjardins du Quebec position in Q2 2026.
Relay Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1760 holding.
258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.